Biography and Research Information
OverviewAI-generated summary
Hannah Shaw's research focuses on understanding the pharmacological effects and potential toxicity of various substances, particularly in combination therapies and overdose scenarios. Her work has investigated the respiratory depressant effects of fentanyl when combined with synthetic cannabinoid receptor agonists, exploring mechanisms that may contribute to overdose resistance to naloxone. Shaw also contributes to the study of cardiovascular function, with a publication examining the diagnostic utility of right sternal edge continuous-wave Doppler in patients with stenotic bicuspid aortic valves. Her scholarship metrics include an h-index of 2, with 8 total publications and 55 citations. Shaw collaborates with colleagues at the University of Arkansas for Medical Sciences, including Brenda M. Gannon, William E. Fantegrossi, and J S James, with whom she has co-authored publications.
Metrics
- h-index: 2
- Publications: 8
- Citations: 55
Selected Publications
-
Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose (2024)
Collaboration Network
Top Collaborators
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose
- Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose
Similar Researchers
Based on overlapping research topics